Literature DB >> 8384489

Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.

D Pennica1, V T Lam, R F Weber, W J Kohr, L J Basa, M W Spellman, A Ashkenazi, S J Shire, D V Goeddel.   

Abstract

An expression plasmid encoding the extracellular domain of the 75-kDa human tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable cell line secreting soluble TNF-R2 (sTNF-R2). Purified sTNF-R2 was resolved by SDS-PAGE into one band of approximate M(r) 43,000, consistent with a molecular weight of 36,000 +/- 4800 obtained by sedimentation equilibrium analysis. The apparent molecular weight observed by gel filtration chromatography was approximately 136,000. Glycosylation analysis revealed that Asn-149 is fully glycosylated, while Asn-171 is incompletely glycosylated (approximately 50%), and that a proline-, serine-, and threonine-rich region (residues 175-234) contains O-linked carbohydrate structures. Scatchard analysis of [125I]TNF-alpha and [125I]TNF-beta binding to sTNF-R2 gave dissociation constants (Kd) of 0.3 and 0.75 nM, respectively, comparable to those observed for intact cell-surface TNF-R2. The sTNF-R2 was found to block the cytotoxicity of both TNF-alpha and TNF-beta in a murine L-M cell assay. The sizes of the sTNF-R2.TNF-alpha and sTNF-R2.TNF-beta complexes determined by gel filtration chromatography were approximately 322 and 204 kDa, respectively. The stoichiometry of the sTNF-R2.TNF-alpha and sTNF-R2.TNF-beta complexes were examined by size-exclusion chromatography, sedimentation equilibrium, and cross-linking. The data from these studies suggest that at least two molecules of sTNF-R2 can bind to a single TNF-alpha or TNF-beta trimer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384489     DOI: 10.1021/bi00063a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.

Authors:  Eric Malaud; Delphine Hourton; Louise Marie Giroux; Ewa Ninio; Robin Buckland; John L McGregor
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

2.  Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Authors:  J C Whitbeck; C Peng; H Lou; R Xu; S H Willis; M Ponce de Leon; T Peng; A V Nicola; R I Montgomery; M S Warner; A M Soulika; L A Spruce; W T Moore; J D Lambris; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

4.  NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2.

Authors:  Montserrat Rodríguez; Lucía Cabal-Hierro; María Teresa Carcedo; Juan Manuel Iglesias; Noelia Artime; Bryant G Darnay; Pedro S Lazo
Journal:  J Biol Chem       Date:  2011-05-10       Impact factor: 5.157

5.  Loss of STAT3 in mouse embryonic fibroblasts reveals its Janus-like actions on mitochondrial function and cell viability.

Authors:  Fouad A Zouein; Roy J Duhé; Istvan Arany; Kristin Shirey; Jonathan P Hosler; Huiling Liu; Iman Saad; Mazen Kurdi; George W Booz
Journal:  Cytokine       Date:  2013-12-31       Impact factor: 3.861

6.  The impact of glycosylation on the pharmacokinetics of a TNFR2:Fc fusion protein expressed in Glycoengineered Pichia Pastoris.

Authors:  Liming Liu; Sujatha Gomathinayagam; Lora Hamuro; Thomayant Prueksaritanont; Weirong Wang; Terrance A Stadheim; Stephen R Hamilton
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

7.  Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).

Authors:  José Alberto Choreño-Parra; Luis Armando Jiménez-Álvarez; Alfredo Cruz-Lagunas; Tatiana Sofía Rodríguez-Reyna; Gustavo Ramírez-Martínez; Montserrat Sandoval-Vega; Diana Lizzeth Hernández-García; Eduardo M Choreño-Parra; Yalbi I Balderas-Martínez; Mariana Esther Martinez-Sánchez; Eduardo Márquez-García; Edda Sciutto; José Moreno-Rodríguez; José Omar Barreto-Rodríguez; Hazel Vázquez-Rojas; Gustavo Iván Centeno-Sáenz; Néstor Alvarado-Peña; Citlaltepetl Salinas-Lara; Carlos Sánchez-Garibay; David Galeana-Cadena; Gabriela Hernández; Criselda Mendoza-Milla; Andrea Domínguez; Julio Granados; Lula Mena-Hernández; Luis Ángel Pérez-Buenfil; Guillermo Domínguez-Cheritt; Carlos Cabello-Gutiérrez; Cesar Luna-Rivero; Jorge Salas-Hernández; Patricio Santillán-Doherty; Justino Regalado; Angélica Hernández-Martínez; Lorena Orozco; Federico Ávila-Moreno; Ethel A García-Latorre; Carmen M Hernández-Cárdenas; Shabaana A Khader; Albert Zlotnik; Joaquín Zúñiga
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

Review 8.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

9.  Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.

Authors:  T J Evans; D Moyes; A Carpenter; R Martin; H Loetscher; W Lesslauer; J Cohen
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

Review 10.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.